accountPARIS - Sanofi-Aventis SA saw its earnings fall by nearly 30 percent in the first quarter as low swine flu vaccine sales battered the French drug maker's bottom line. The world's fourth largest prescription drug maker by sales said in a statement...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Sanofi-Aventis First-Quarter Profit Falls
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account